Explained: What is Dostarlimab, an antibody drug used in rectal cancer trial?

Explained: What is Dostarlimab, an antibody drug used in rectal cancer trial?

Dostarlimab, sold under the brand name Jemperli, developed by Tesaro, is a monoclonal antibody used to target cancer. New Delhi, Jun 08: A small clinical experiment discovered that 18 patients suffering from rectal cancer saw their disease vanish, in what looks

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News